{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:34:46Z","timestamp":1788834886183,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate the possible influence of prolonged ketamine (K) or esketamine (ESK) infusion on the profile of liver cholestatic biomarkers in patients with COVID-19 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was performed on 135 patients with COVID-19 related ARDS who received prolonged K or ESK infusion. They were compared to 15 COVID-19 ICU patients who did not receive K\/ESK while being mechanically ventilated and 108 COVID-19 patients who did not receive mechanical ventilation nor K\/ESK. The profile of the liver function tests was analysed in the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Peak values of ALP, GGT and bilirubin were higher in the K\/ESK group, but not for AST and ALT. Peak values of ALP were significantly higher among patients who underwent mechanical ventilation and who received K\/ESK, compared with mechanically ventilated patients who did not receive K\/ESK. There was a correlation between these peak values and the cumulative dose and duration of K\/ESK therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on the observations of biliary anomalies in chronic ketamine abusers, prolonged exposure to ketamine sedation during mechanical ventilation may also be involved, in addition to viral infection causing secondary sclerosing cholangitis. The safety of prolonged ketamine sedation on the biliary tract requires further investigations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-023-02006-2","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:02:56Z","timestamp":1675728176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19"],"prefix":"10.1186","volume":"23","author":[{"given":"Julie","family":"Henrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Declerfayt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Baldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Laterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hantson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"issue":"4","key":"2006_CR1","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1213\/ANE.0000000000005131","volume":"131","author":"CM Kapp","year":"2020","unstructured":"Kapp CM, Zaeh S, Niedermeyer S, Punjabi NM, Siddharthan T, Damarla M. The Use of Analgesia and Sedation in Mechanically Ventilated Patients With COVID-19 Acute Respiratory Distress Syndrome. Anesth Analg. 2020;131(4):e198\u2013200.","journal-title":"Anesth Analg"},{"key":"2006_CR2","first-page":"1","volume":"26","author":"K Karamchandani","year":"2021","unstructured":"Karamchandani K, Dalal R, Patel J, Modgil P, Quintili A. Challenges in Sedation Management in Critically Ill Patients with COVID-19: a Brief Review. Curr Anesthesiol Rep. 2021;26:1\u20139.","journal-title":"Curr Anesthesiol Rep"},{"issue":"3","key":"2006_CR3","first-page":"288","volume":"39","author":"PM Garber","year":"2019","unstructured":"Garber PM, Droege CA, Carter KE, Harger NJ, Mueller EW. Continuous Infusion Ketamine for Adjunctive Analgosedation in Mechanically Ventilated. Critically Ill Patients Pharmacotherapy. 2019;39(3):288\u201396.","journal-title":"Critically Ill Patients Pharmacotherapy"},{"issue":"12","key":"2006_CR4","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s00134-020-06307-9","volume":"46","author":"G Chanques","year":"2020","unstructured":"Chanques G, Constantin JM, Devlin JW, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46(12):2342\u201356.","journal-title":"Intensive Care Med"},{"issue":"9","key":"2006_CR5","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation\/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825\u201373.","journal-title":"Crit Care Med"},{"issue":"10","key":"2006_CR6","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00134-021-06482-3","volume":"47","author":"C de Tymowski","year":"2021","unstructured":"de Tymowski C, D\u00e9pret F, Dudoignon E, Legrand M, Mallet V, Keta-Cov Research Group. Ketamine-induced cholangiopathy in ARDS patients. Intensive Care Med. 2021;47(10):1173\u20134.","journal-title":"Intensive Care Med"},{"issue":"12","key":"2006_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40264-021-01120-9","volume":"44","author":"S Cotter","year":"2021","unstructured":"Cotter S, Wong J, Gada N, et al. Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series. Drug Saf. 2021;44(12):1365\u201374.","journal-title":"Drug Saf"},{"issue":"1","key":"2006_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jhep.2018.03.006","volume":"69","author":"WK Seto","year":"2018","unstructured":"Seto WK, Mak SK, Chiu K, et al. Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users. J Hepatol. 2018;69(1):121\u20138.","journal-title":"J Hepatol"},{"issue":"1","key":"2006_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/24734306.2021.1925443","volume":"5","author":"I Ferraz de Oliveira","year":"2021","unstructured":"Ferraz de Oliveira I, Mesland JB, Laterre PF, Hantson P. Triad of obstructive uropathy, cholestasis, and pneumomediastinum associated with chronic ketamine abuse: a case report. Toxicology Communications. 2021;5(1):115\u20138.","journal-title":"Toxicology Communications"},{"issue":"3","key":"2006_CR10","first-page":"52","volume":"52","author":"RS Lo","year":"2011","unstructured":"Lo RS, Krishnamoorthy R, Freeman JG, Austin AS. Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series. Singapore Med J. 2011;52(3):52\u20135.","journal-title":"Singapore Med J"},{"issue":"9","key":"2006_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1442-2042.2007.01834.x","volume":"14","author":"SM Jankovic","year":"2007","unstructured":"Jankovic SM, Jankovic SV, Stojadinovic D, Jakovljevic M, Milovanovic D. Effect of exogenous glutamate and N-Methyl-D-aspartic acid on spontaneous activity of isolated human ureter. Int J Urol. 2007;14(9):833\u20137.","journal-title":"Int J Urol"},{"issue":"6","key":"2006_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0897190014525754","volume":"27","author":"G Bokor","year":"2014","unstructured":"Bokor G, Anderson PD. Ketamine: an update on its abuse. J Pharm Pract. 2014;27(6):582\u20136.","journal-title":"J Pharm Pract"},{"issue":"2","key":"2006_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1042\/cs0820169","volume":"82","author":"A Thune","year":"1992","unstructured":"Thune A, Jiveg\u00e5rd L, Pollard H, Moreau J, Schwartz JC, Svanvik J. Location of enkephalinase and functional effects of [Leu5] enkephalin and inhibition of enkephalinase in the feline main pancreatic and bile duct sphincters. Clin Sci. 1992;82(2):169\u201373.","journal-title":"Clin Sci"},{"issue":"5","key":"2006_CR14","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jhep.2021.02.007","volume":"74","author":"Keta-Cov research group","year":"2021","unstructured":"Keta-Cov research group. lectronic address: vincent.mallet@aphp.fr; Keta-Cov research group. Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. J Hepatol. 2021;74(5):1243\u20134.","journal-title":"J Hepatol"},{"issue":"3","key":"2006_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73(3):566\u201374.","journal-title":"J Hepatol"},{"issue":"1","key":"2006_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.14218\/JCTH.2020.00018","volume":"8","author":"G Feng","year":"2020","unstructured":"Feng G, Zheng KI, Yan QQ, et al. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol. 2020;8(1):18\u201324.","journal-title":"J Clin Transl Hepatol"},{"issue":"9","key":"2006_CR17","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1111\/liv.14455","volume":"40","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city. China Liver Int. 2020;40(9):2095\u2013103.","journal-title":"China Liver Int"},{"issue":"3","key":"2006_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/hep.31326","volume":"73","author":"PP Bloom","year":"2021","unstructured":"Bloom PP, Meyerowitz EA, Reinus Z, et al. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021;73(3):890\u2013900.","journal-title":"Hepatology"},{"issue":"7","key":"2006_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/2050640620931657","volume":"8","author":"JM Schattenberg","year":"2020","unstructured":"Schattenberg JM, Labenz C, W\u00f6rns MA, et al. Patterns of liver injury in COVID-19 - a German case series. United European Gastroenterol J. 2020;8(7):814\u20139.","journal-title":"United European Gastroenterol J"},{"issue":"10223","key":"2006_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497\u2013506.","journal-title":"China Lancet"},{"issue":"11","key":"2006_CR21","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan. China JAMA. 2020;323(11):1061\u20139.","journal-title":"China JAMA"},{"issue":"9","key":"2006_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/MEG.0000000000001827","volume":"33","author":"C Labenz","year":"2021","unstructured":"Labenz C, Toenges G, W\u00f6rns MA, Sprinzl MF, Galle PR, Schattenberg JM. Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2021;33(9):1194\u2013200.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"2006_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MOG.0000000000000808","volume":"38","author":"A Bartoli","year":"2022","unstructured":"Bartoli A, Cursaro C, Andreone P. Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies. Curr Opin Gastroenterol. 2022;38(2):89\u201397.","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"2006_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.14309\/ajg.0000000000001154","volume":"116","author":"NC Roth","year":"2021","unstructured":"Roth NC, Kim A, Vitkovski T, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116(5):1077\u2013108.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2006_CR25","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.14309\/ajg.0000000000001264","volume":"116","author":"S Faruqui","year":"2021","unstructured":"Faruqui S, Okoli FC, Olsen SK, et al. Cholangiopathy after severe COVID-19: clinical features and prognostic implications. Am J Gastroenterol. 2021;116(7):1414\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2006_CR26","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.transproceed.2021.03.007","volume":"53","author":"FA Durazo","year":"2021","unstructured":"Durazo FA, Nicholas AA, Mahaffey JJ, et al. Post-Covid-19 cholangiopathy-a new indication for liver transplantation: a case report. Transplant Proc. 2021;53(4):1132\u20137.","journal-title":"Transplant Proc"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clinimag.2021.07.017","volume":"80","author":"S Tafreshi","year":"2021","unstructured":"Tafreshi S, Whiteside I, Levine I, D\u2019Agostino C. A case of secondary sclerosing cholangitis due to COVID-19. Clin Imaging. 2021;80:239\u201342.","journal-title":"Clin Imaging"},{"issue":"8","key":"2006_CR28","doi-asserted-by":"publisher","first-page":"e244168","DOI":"10.1136\/bcr-2021-244168","volume":"14","author":"A Lee","year":"2021","unstructured":"Lee A, Wein AN, Doyle MBM, Chapman WC. Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep. 2021;14(8):e244168.","journal-title":"BMJ Case Rep"},{"issue":"5","key":"2006_CR29","doi-asserted-by":"publisher","first-page":"e04068","DOI":"10.1002\/ccr3.4068","volume":"9","author":"C Klindt","year":"2021","unstructured":"Klindt C, Jensen BE, Brandenburger T, et al. Secondary sclerosing cholangitis as a complication of severe COVID-19: a case report and review of the literature. Clin Case Rep. 2021;9(5):e04068.","journal-title":"Clin Case Rep"},{"key":"2006_CR30","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.jtauto.2021.100116","volume":"4","author":"M Rojas","year":"2021","unstructured":"Rojas M, Rodr\u00edguez Y, Zapata E, Hern\u00e1ndez JC, Anaya J. Cholangiopathy as part of post-COVID syndrome. J Transl Autoimmun. 2021;4:100116.","journal-title":"J Transl Autoimmun"},{"issue":"6","key":"2006_CR31","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.32582","volume":"76","author":"L Hartl","year":"2022","unstructured":"Hartl L, Haslinger K, Angerer M, et al. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hepatology. 2022;76(6):1563\u201375.","journal-title":"Hepatology"},{"issue":"9","key":"2006_CR32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00134-021-06445-8","volume":"47","author":"P Meersseman","year":"2021","unstructured":"Meersseman P, Blondeel J, De Vlieger G, van der Merwe S, Monbaliu D. Collaborators Leuven Liver Transplant program. Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients. Intensive Care Med. 2021;47(9):1037\u201340.","journal-title":"Intensive Care Med"},{"issue":"1","key":"2006_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/hep.31650","volume":"74","author":"SAI Knooihuizen","year":"2021","unstructured":"Knooihuizen SAI, Aday A A, Lee WM. Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19. Hepatology. 2021;74(1):519\u201321.","journal-title":"Hepatology"},{"issue":"10","key":"2006_CR34","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1111\/liv.14971","volume":"41","author":"S B\u00fctikofer","year":"2021","unstructured":"B\u00fctikofer S, Lenggenhager D, Wendel Garcia PD, et al. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int. 2021;41(10):2404\u201317.","journal-title":"Liver Int"},{"issue":"1","key":"2006_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13054-022-04019-8","volume":"26","author":"PD Wendel-Garcia","year":"2022","unstructured":"Wendel-Garcia PD, Erlebach R, Hofmaenner DA, et al. Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome. Crit Care. 2022;26(1):148.","journal-title":"Crit Care"},{"issue":"4","key":"2006_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00428-008-0654-1","volume":"453","author":"I Esposito","year":"2008","unstructured":"Esposito I, Kubisova A, Stiehl A, Kulaksiz H, Schirmacher P. Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis. Virchows Arch. 2008;453(4):339\u201345.","journal-title":"Virchows Arch"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-023-02006-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:03:59Z","timestamp":1675728239000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-023-02006-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1186\/s12871-023-02006-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1664793\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"17 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (IRB) (Cliniques Universitaires Saint-Luc (CUSL)). The research has been performed in accordance with the Declaration of Helsinki.A written informed consent from the participants was waived by the Institutional Review Board (Cliniques Universitaires Saint-Luc (CUSL) as the research was based on a retrospective analysis of an anonymized database with the patients chart data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}